Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Riccardo Vidotto"'
Autor:
Maria Chiara Scaini, Cristina Catoni, Cristina Poggiana, Jacopo Pigozzo, Luisa Piccin, Kevin Leone, Ilaria Scarabello, Antonella Facchinetti, Chiara Menin, Lisa Elefanti, Stefania Pellegrini, Valentina Aleotti, Riccardo Vidotto, Francesca Schiavi, Alessio Fabozzi, Vanna Chiarion-Sileni, Antonio Rosato
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-16 (2024)
Abstract Melanoma heterogeneity is a hurdle in metastatic disease management. Although the advent of targeted therapy has significantly improved patient outcomes, the occurrence of resistance makes monitoring of the tumor genetic landscape mandatory.
Externí odkaz:
https://doaj.org/article/168759f0adb14fe5b0f672e54dd70bb5
Autor:
Paolo Bonvini, Elisabetta Rossi, Angelica Zin, Mariangela Manicone, Riccardo Vidotto, Antonella Facchinetti, Lucia Tombolan, Maria Carmen Affinita, Luisa Santoro, Rita Zamarchi, Gianni Bisogno
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Inflammatory myofibroblastic tumors (IMTs) are locally aggressive malignancies occurring at various sites. Surgery is the mainstay of treatment and prognosis is generally good. For children with unresectable or metastatic tumors, however, outcome is
Externí odkaz:
https://doaj.org/article/f4c3cf0426bc4c068047ca91f23dfb3e
Autor:
Sanne de Wit, Antonella Facchinetti, Leon W.M.M. Terstappen, Menno Tamminga, T. Jeroen N. Hiltermann, Ellen Heitzer, Rita Zamarchi, Mariangela Manicone, Joost F. Swennenhuis, Elisabetta Rossi, Ed Schuuring, Harry J.M. Groen, Riccardo Vidotto, Sabrina Weber, Michael R. Speicher, Catharina G.M. Groothuis-Oudshoorn, Leonie L. Zeune
Publikováno v:
International Journal of Cancer, 144(12), 3127-3137. Wiley
International journal of cancer, 144(12), 3127-3137. Wiley
International journal of cancer, 144(12), 3127-3137. Wiley
The need for a liquid biopsy in non-small cell lung cancer (NSCLC) patients is rapidly increasing. We studied the relation between overall survival (OS) and the presence of four cancer biomarkers from a single blood draw in advanced NSCLC patients: E
Autor:
Erica Melchiotti, P Laganga, Katia Capello, Claudia Zanardello, Riccardo Vidotto, Elisabetta Rossi, Rita Zamarchi, Antonella Facchinetti, Laura Marconato, Marta Vascellari
Publikováno v:
Cancers
Volume 11
Issue 2
Cancers, Vol 11, Iss 2, p 163 (2019)
Volume 11
Issue 2
Cancers, Vol 11, Iss 2, p 163 (2019)
In human breast cancer, both circulating tumour cells (CTCs) in peripheral blood and disseminated tumour cells (DTCs) in the bone marrow are predictive of short survival and may be used as liquid biopsy to guide therapy. Herein we investigate, for th
Autor:
Agostino Steffan, Matteo Turetta, Simon Spazzapan, Eva Biscontin, Rita Zamarchi, Fabio Del Ben, Giulia Brisotto, Alfonso Colombatti, Riccardo Vidotto, Daniela Cesselli, Cristina Poggiana, Wilhelm T. S. Huck, Michela Bulfoni, Elisabetta Rossi, Aigars Piruska
Publikováno v:
Cancers
Volume 12
Issue 4
Cancers, 12, 4
Cancers, Vol 12, Iss 1005, p 1005 (2020)
Cancers, 12
Volume 12
Issue 4
Cancers, 12, 4
Cancers, Vol 12, Iss 1005, p 1005 (2020)
Cancers, 12
Circulating tumor cells (CTCs) belong to a heterogeneous pool of rare cells, and a unequivocal phenotypic definition of CTC is lacking. Here, we present a definition of metabolically-altered CTC (MBA-CTCs) as CD45-negative cells with an increased ext
Autor:
Rita Zamarchi, Maarten Joost IJzerman, Beate Zill, Johann S. de Bono, Anne Margreet Sofie Berghuis, Mariane Sousa Fontes, M Tzschaschel, Penelope Flohr, Gemma Fowler, Françoise Farace, Mateus Crespo, Liwen Yang, Sanne de Wit, Rita Lampignano, Alvera Rengel-Puertas, Elisabeth Trapp, Brigitte Rack, Riccardo Vidotto, Emeline Colomba, Marianna Alunni-Fabbroni, Elisabetta Rossi, Hans Neubauer, Mariangela Manicone, Pasquale Rescigno, Leonardus Wendelinus Mathias Marie Terstappen, Kiki C. Andree, Marianne Ouhlen, Tanja Fehm
Publikováno v:
Oncotarget, 9(86), 35705-35716. Impact Journals
Oncotarget, 9(86), 35705-35716. Impact Journals LLC
Oncotarget
Oncotarget, 9(86), 35705-35716. Impact Journals LLC
Oncotarget
The presence of high expressing epithelial cell adhesion molecule (EpCAMhigh) circulating tumor cells (CTC) enumerated by CellSearch® in blood of cancer patients is strongly associated with poor prognosis. This raises the question about the presence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bb8a16db1f47625c7515c29b34d629b
https://research.utwente.nl/en/publications/a8a041a9-63c1-4e0f-9c6a-7b3ebe624dc7
https://research.utwente.nl/en/publications/a8a041a9-63c1-4e0f-9c6a-7b3ebe624dc7
Autor:
Françoise Farace, Rita Zamarchi, Mariangela Manicone, Sanne de Wit, Elisabeth Trapp, Emeline Colomba, Marianna Alunni-Fabbroni, Hans Neubauer, Leon W.M.M. Terstappen, Johann S. de Bono, Penelope Flohr, Mariane Sousa Fontes, Mateus Crespo, Gemma Fowler, Marianne Oulhen, Rita Lampignano, Riccardo Vidotto, Brigitte Rack, Kiki C. Andree, Marie Tzschaschel, Joost F. Swennenhuis, Elisabetta Rossi, Tanja Fehm
Publikováno v:
Cancer Research. 77:3787-3787
Introduction: The presence of circulating tumor cells (CTC) enumerated by the CellSearch system in blood of patients with cancers of epithelial origin is strongly associated with a poor prognosis of these patients. CTC are enriched by targeting the E